ELIFE HLDGS (00223) Reports Interim Profit of HK$4.365 Million
Stock News
Nov 28
ELIFE HLDGS (00223) announced its six-month results for the period ended September 30, 2025. Revenue from continuing operations amounted to HK$60.928 million, representing a year-on-year decline of 49.0%. The company recorded a profit attributable to shareholders of HK$4.365 million, compared to a loss of HK$69.94 million in the same period last year. Basic earnings per share stood at HK$0.003. This turnaround from loss to profit marks a significant recovery, demonstrating the successful implementation of management's strategy to stabilize and restore the group's business operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.